Development and in vitro evaluation of ibuprofen mouth dissolving tablets using solid dispersion technique

Chemical and Pharmaceutical Bulletin

Volumn 58, Issue 8, 2010, Pages 1037-1042

  Jain, Sunil Kumar ^a   Shukla, Meenakshi ^b   Shrivastava, Vivek ^c  

^a GURU GHASIDAS UNIVERSITY   (India)

^b Bansal College of Pharmacy   (India)

^c Bhopal Institute of Technology and Science Pharmacy   (India)

Author keywords

Dissolution; Hydrophilic carrier; Ibuprofen; Mouth dissolving tablet; Solid dispersion

Indexed keywords

IBUPROFEN;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSIBLE TABLET; DISPERSION; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; TABLET FORMULATION; X RAY DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; DRUG DESIGN; DRUG STABILITY; IBUPROFEN; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS; X-RAY DIFFRACTION;

EID: 77955368629     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.58.1037     Document Type: Article

References (32)

1. Van den Mooter G., Wuyts M., Blaton N., Busson R., Grobet P., Augustijns P., Kinget R., Eur. J. Pharm. Sci., 12, 261-269 (2001).
2. Ford J. L., Pharm. Acta Helv., 58, 101-08 (1983).
3. Szente L., Apostol L., Gerloczy A., Szejtli J., Pharmazie, 40, 406-407 (1985).
4. Patel D. M., Shah R. R., Jogani P. D., Ind. J. Pharm. Sci., 66, 49-55 (2004).
5. Madhusudhan B., Rambhau D., Gudsoorkar V. R., Shete J. S., Apte S. S., Ind. J. Pharm. Sci., 64, 233-238 (2002).
6. Okonogi S., Puttipipatkhachorn S., AAPS PharmSciTech, 7, Article 52 (2006).
7. Owusu-Ababio G., Ebube N. K., Reams R., Habib M., Pharm. Dev. Technol., 3, 405-412 (1998).
8. Schachter D. M., Xiong J., Int. J. Pharm., 281, 89-101 (2004).
9. Sethia S., Squillante E., Int. J. Pharm., 272, 1-10 (2004).
10. Okimoto K., Miyake M., Ibuki R., Yasumura M., Ohnishi N., Nakai T., Int. J. Pharm., 159, 85-93 (1997).
11. Damian F., Blaton N., Kinget R., Van der Mooter G., Int. J. Pharm., 244, 87-98 (2002).
12. Nakamichi K., Nakano T., Yasuura H., Izumi S., Kawashima Y., Int. J. Pharm., 241, 203-211 (2002).
13. Craig D. Q. M., Drug Dev. Ind. Pharm., 16, 2501-2506 (1990).
14. Newa M., Bhandari K. H., Kin J. O., Im J. S., Kim J. A., Yoo B. K., Woo J. S., Choi H. G., Yong C. S., Chem. Pharm. Bull., 56, 569-574 (2008).
15. Sammour O. A., Hammad M. A., Megrab N. A., Zidan A. S., AAPS PharmSciTech, 7, Article 55 (2006).
16. Oshima T., Sonoda R., Ohkuma M., Sunada H., Chem. Pharm. Bull., 55, 1557-1562 (2007).
17. Patel M. M., Patel D. M., Ind. J. Pharm. Sci., 68, 222-226 (2006).
18. Giri T. K., Jana P., Sa B., J. Sci. Ind. Res., 67, 436-439 (2008).
19. Valleri M., Mura P., Maestrelli M., Cirri M., Ballerini R., Drug Dev. Ind. Pharm., 30, 525-534 (2004).
20. Bhalerao A. V., Deshkar S. S., Shirolkar S. V., Gharge V. G., Deshpande A. D., Res. J. Pharm. Tech., 2, 375-377 (2009).
21. Brunton L. L., Parker K. L., Blumenthal D. K., Buxton I. L. O., "Goodman & Gillman's Manual of Pharmacology & Therapeutics," McGraw-Hill Medical Publishing Division, U.S.A., 2008, pp. 452-453.
22. Sethia S., Squillante E., J. Pharm. Sci., 91, 1948-1957 (2002).
23. Verheyan S., Blaton N., Kinget R., Van der Mooter G., Int. J. Pharm., 249, 45-58 (2002).
24. Florey K., "Analytical Profile of Drug Substances," Vol. 27, Elsevier Imprint, New York, 2005, pp. 268-297.
25. Ghoel M., Patel M., Amin A., Agrawal R., Dave R., Bariya N., AAPS PharmSciTech, 5, Article 36 (2004).
26. James E., Singh G., Larry L., Vinod P., J. Pharm. Sci., 86, 690-700 (1997).
27. Wu P. C., Tsai M. J., Huang Y. B., Cheng J. S., Tsai Y. H., Int. J. Pharm., 243, 119-124 (2002).
28. Yamashita K., Nakate T., Okimoto K., Ohike A., Int. J. Pharm., 267, 79-91 (2003).
29. Betageri G. V., Markala K. R., Int. J. Pharm., 126, 155-160 (1995).
30. Jung J. Y., Yoo S. D. F., Lee S. H., Kin K. H., Yoo D. S., Lee K. H., Int. J. Pharm., 187, 209-218 (1999).
31. Rao M. G., Suneetha R., Reddy P. S., Ravi T. K., Ind. J. Pharm. Sci., 67, 61-75 (2005).
32. Mesnukul A., Yodkhum K., Phaechamud T., Ind. J. Pharm. Sci., 71, 413-420 (2009).